DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: An association study

Psychiatric Genetics

Volumn 18, Issue 1, 2008, Pages 25-30

  Schwab, Sibylle G ^a,b,e   Plummer, Christie ^a,b   Albus, Margot ^d   Borrmann Hassenbach, Margitta ^d   Lerer, Bernard ^f   Trixler, Matyas ^g   Maier, Wolfgang ^e   Wildenauer, Dieter B ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c GRAYLANDS HOSPITAL   (Australia)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^g UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cognitive deficits; Family based association analysis; Metabotropic glutamate receptor 3; Schizophrenia; Stroop color naming test; Trail making test B

Indexed keywords

METABOTROPIC RECEPTOR 3;

ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; GENE REPLICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; NEUROPSYCHOLOGICAL TEST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; RISK FACTOR; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ALLELES; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 7; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 38149035286     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3282ef48d9     Document Type: Article

References (24)

1. Becker T, Knapp M (2004a). Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 27:21-32.
2. Becker T, Knapp M (2004b). A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 75:561-570.
3. Bishop JR, Ellingrod VL, Moline J, Miller D (2005). Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr Res 77:253-260.
4. Braver TS, Barch DM, Cohen JD (1999). Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry 46:312-328.
5. Chen Q, He G, Chen Q, Wu S, Xu Y, Feng G, et al. (2005). A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr Res 73:21-26.
6. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, et al. (2004). Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 101:12604-12609.
7. 2+ stores and ion channels in neurons. Trends Neurosci 23:80-88.
8. Fuji Y, Shibata H, Kikuta R, Makino C, Tani A, Hirata N, et al. (2003). Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 13:71-76.
9. Fyer A, Endicott J, Manuzza S, Klein D (1985). Schedule for affective disorders and schizophrenia-lifetime version (SADS-LA). New York: New York State Psychiatric Institute.
10. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. (2002). The structure of haplotype blocks in the human genome. Science 296:2225-2229.
11. Itil T, Keskiner A, Kiremitci N, Holden JM (1967). Effect of phencyclidine in chronic schizophrenics. Can Psychiatr Assoc J 12:209-212.
12. Knapp M, Becker T (2003). Family-based association analysis with tightly linked markers. Hum Hered 56:2-9.
13. Li J, Ji L (2005). Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95:221-227.
14. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959). Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81:363-369.
15. MacLeod CM (1991). Half a century of research on the Stroop effect: an integrative review. Psychol Bull 109:163-203.
16. Marti SB, Cichon S, Propping P, Nothen M (2002). Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population. Am J Med Genet 114:46-50.
17. Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352.
18. Norton N, Williams HJ, Dwyer S, Ivanov D, Preece AC, Gerrish A, et al. (2005). No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry 5:23.
19. Nyholt DR (2004). A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769.
20. Purcell S, Cherny SS, Sham PC (2003). Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.
21. Sartorius LJ, Nagappan G, Lipska BK, Lu B, Sei Y, Ren-Patterson R, et al. (2006). Alternative splicing of human metabotropic glutamate receptor 3. J Neurochem 96:1139-1148.
22. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. (2005). Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58:446-450.
23. Spitzer R, Endicott J, Robins E (1978). Research diagnostic criteria for a selected group of functional disorders. New York: New York State Psychiatric Institute.
24. Stroop JR (1935). Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662.